Rxsight, Inc. income statement

In fiscal 2025, Rxsight, Inc. reported revenue of $134m, down 3.9% on the year before, operating income of −$48.2m (a -35.8% margin) and net income of −$38.9m, or −$0.95 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Rxsight, Inc.: income statement, annual
Fiscal year	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	15	23	49	89	140	134	128
Cost of revenue	13	18	28	35	41	31	29
Gross profit	2	5	21	54	99	103	99
Research and development	22	24	26	29	34	39	37
Selling, general and administrative	15	33	59	75	101	113	117
Operating income	−35	−53	−63	−50	−37	−48	−55
Interest expense	1	4	5	3	0	0	0
Income before tax	28	−49	−67	−49	−27	−39	−47
Income tax	0	0	0	0	0	0	0
Net income	28	−49	−67	−49	−27	−39	−47
Diluted EPS	$0.07	−$1.78	−$2.41	−$1.41	−$0.71	−$0.95	−$1.14
Diluted shares (average)	11m	27m	28m	34m	39m	41m	41m
EBITDA	−32	−49	−59	−46	−33	−45	−52

US$ millions unless shown otherwise. Fiscal quarters.

Rxsight, Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	35	40	38	34	30	33	31	34
Cost of revenue	10	11	10	8	6	7	7	8
Gross profit	25	29	28	25	24	25	23	26
Research and development	9	9	10	10	9	9	9	9
Selling, general and administrative	26	28	29	29	27	28	32	30
Operating income	−9	−9	−11	−14	−12	−11	−18	−14
Interest expense	0	0	0	0	0	0	0	0
Income before tax	−6	−6	−8	−12	−10	−9	−16	−12
Income tax	0	0	0	0	0	0	0	0
Net income	−6	−6	−8	−12	−10	−9	−16	−12
Diluted EPS	−$0.16	−$0.15	−$0.20	−$0.29	−$0.24	−$0.22	−$0.38	−$0.29
EBITDA	−8	−8	−10	−13	−11	−10	−17	−13

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BBNX vs RXST ANIK vs RXST OM vs RXST INFU vs RXST

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Rxsight, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Rxsight, Inc.